Gundeep Dhillon, MD, MPH

Publication Details

  • Clarithromycin for prevention of bronchiolitis obliterans syndrome in lung allograft recipients.

    Dhillon GS, Valentine VG, Levitt J, Patel P, Gupta MR, Duncan SR, Seoane L, Weill D. Clin Transplant. 2012 Jan-Feb; 26 (1): 105-10

    Bronchiolitis obliterans syndrome (BOS) is the major limitation to long-term survival following lung transplantation and strategies to reduce its incidence have remained elusive. Macrolides may stabilize lung function in patients with established BOS. Their role, however, in prevention of BOS remains unexamined.

    PubMedID: 21352378

Stanford Medicine Resources:

Footer Links: